Navigation Links
NJBIZ Honors New Jersey's General Counsels
Date:4/1/2013

WOODCLIFF LAKE, N.J., April 1, 2013 /PRNewswire/ -- Martin L. Wilson, Chief Counsel, Compliance & Litigation, has been named a finalist in the Corporate Compliance Professional category in the 2013 NJBIZ General Counsel of the Year Awards program.  The award program, produced by NJBIZ, New Jersey's premiere business news publication, is sponsored by Nicoll Davis & Spinella LLP, Real Estate Strategies, Update Discovery, Gibbons P.C., Archer & Greiner P.C., K&L Gates, Budd Larner , and Deloitte.  

The General Counsel of the Year Awards program honors New Jersey's standout General Counsels, Chief Legal Officers and corporate compliance professionals for the critical role they play in making their companies successful.  Finalists were selected in six categories: Public Company with revenues up to $1 Billion, Public Company with revenues of more than $1 Billion, Corporate Compliance Professional, Private Company with revenues up to $1 Billion, Private Company with revenues of more than $1 Billion, and Non-profit or Government Organization. 

Finalists and winners were chosen by an independent panel of judges including: Mayor Gerald R. Drasheff , Christine Pellizzari , Christopher Klein , and Anthony Tinari .  Honorees were selected using a scoring system based on: career successes, legal victories and achievements, professional services provided and community service. 

The General Counsel of the Year Awards finalists will be recognized and the winners in each category will be announced during a breakfast awards ceremony on Thursday, June 6, 2013 at the Palace in Somerset Park in Somerset, NJ. 

For more information about the NJBIZ General Counsel of the Year Awards program or to reserve seats to the event, please visit www.njbiz.com/events or contact Melissa Sullenberger at melissas@njbiz.com or (732) 246-5737.  

About Par Pharmaceutical Companies, Inc. 

Par Pharmaceutical Companies, Inc. is a privately held, U.S.-based specialty pharmaceutical company that develops, manufactures and markets high barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals.  For press release and other company information, visit www.parpharm.com


'/>"/>
SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Med Ad News Honors Healthcare Communication Agencies at 23rd Annual Manny Awards
2. Premier healthcare alliance honors Atrium Medical Corporation for operational excellence
3. GlaxoSmithKline honors healthcare nonprofits with $40,000 IMPACT Award
4. Frost & Sullivan Honors Acuo Technologies with 2012 Market Share Leadership Award in Enterprise Imaging Informatics
5. iSALUS Healthcares chairman receives national honors from Samaritans Purse - an international organization providing spiritual and physical aid to victims of war, poverty, natural disaster and disease.
6. ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report
7. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
8. Leading Pension Annuity Provider Legal & General, Celebrates 175 Years
9. Hospira and Lancaster General Hospital Honored for Patient Safety Initiatives
10. PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital
11. Amsterdam Molecular Therapeutics (AMT) Holding N.V. (in liquidation) Announces Publication of its Accounts for 2011 and Notice of Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... Dec. 7, 2016 KEY FINDINGS ... benefits such as reducing loss of blood during ... cardiac arrests, rapid recovery after surgeries, and decreasing ... be segmented into convective warming system, surface warming ... turn reduce the stay at hospitals thus, lowering ...
(Date:12/7/2016)... DUBLIN , Dec 7, 2016 Research ... Product, Application and End User - Global Forecast to 2021" report ... , , ... reach USD 2.12 Billion by 2021, growing at a CAGR of 7.3% ... such as the growing prevalence of cancer and rapidly increasing geriatric population ...
(Date:12/7/2016)... , Dec. 7, 2016 DelveInsight,s, ... report provides in depth insights on the ... the Janus Kinase 3 (JAK3) Inhibitors. The ... various stages of development including Discovery, Pre-clinical, ... and Preregistration. Report covers the product clinical ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... 2016 , ... ODU, a worldwide leader in designing ... advanced highly customizable contact technology solutions. , ODU Single Contact Technology portfolio includes: ... for a wide range of applications that require customization from industries like emobility, ...
(Date:12/7/2016)... ... December 07, 2016 , ... Augustine ... services to families and business owners in the greater Dallas metropolitan area, is ... Dallas Fallen Officer Foundation. , Established in 2009 by active police professionals in ...
(Date:12/7/2016)... ... 2016 , ... A. Kevin Spann Insurance, a New York-based firm offering insurance ... launching a charity drive to raise funds that will benefit the Marine Corps League. ... and Navy FMF Corpsmen. Working closely with the MCL, the A. Kevin Spann team ...
(Date:12/7/2016)... ... December 07, 2016 , ... The ... its fully redesigned website, which launched October 17, 2016, features comprehensive information regarding ... and easy-to-navigate layout. Visitors and patients can discover the latest clinical dermatology treatments ...
(Date:12/7/2016)... Dallas, TX (PRWEB) , ... December 07, 2016 ... ... service based in Dallas, Texas, is condemning "scam operations" carried out by unethical ... to bring these scam operations to a halt. According to Texas Premier Locksmith, ...
Breaking Medicine News(10 mins):